Global Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Product (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy, Needle Based Biopsy Guns, Biopsy Needles), Procedure (Image-guided Procedures, Ultrasound-guided Procedures, Stereotactic Procedures, CT-guided Procedures, MRI-guided Procedures, and Other Procedures), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour/Cancer, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2031.
Needle Biopsy Market Analysis and Size
In Europe, with breast cancer cases projected to rise from 531,000 in 2020 to 568,000 by 2040, needle biopsy procedures play a crucial role in early diagnosis. As the most prevalent cancer type, needle biopsies aid in early and accurate diagnosis, guiding treatment decisions. The increasing incidence underscores the pivotal role of needle biopsy technologies in breast cancer management.
Data Bridge Market Research analyses that the global needle biopsy market which was USD 125.51 million in 2023, is expected to reach USD 174.43 million by 2031, and is expected to undergo a CAGR of 4.2% during the forecast period of 2024 to 2031. This indicates that the market value. “Fine-needle aspiration biopsy” is expected to dominate the procedure segment of the needle biopsy market due to its minimally invasive nature. This technique allows for precise tissue sampling with minimal patient discomfort and rapid recovery. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Needle Biopsy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Product (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy, Needle Based Biopsy Guns, Biopsy Needles), Procedure (Image-guided Procedures, Ultrasound-guided Procedures, Stereotactic Procedures, CT-guided Procedures, MRI-guided Procedures, and Other Procedures), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour/Cancer, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Medax (Italy), Boston Scientific Corporation (U.S.) Cook Group (U.S.) Hologic, Inc. (U.S.), ST. STONE MEDICAL DEVICES PVT. LTD. (India), AprioMed AB (Sweden), AMECATH (Egypt), ZAMAR CARE. (Croatia), Cardinal Health (U.S.), INRAD, Inc. (U.S.), BD (U.S.), MÖLLER Medical GmbH (Germany), HAKKO CO.,LTD. (Japan), Argon Medical Devices (U.S.), Merit Medical Systems. (U.S.), weLLgo Medical Products GmbH (Germany), Swastik Enterprise (India), Tsunami Medical (Italy), PAJUNK (Germany) and B. Braun SE (Germany)
|
|
Market Opportunities
|
|
Market Definition
Needle biopsy is a minimally invasive procedure crucial for diagnostic tissue sampling. Utilizing a thin, hollow needle, it extracts samples from suspicious areas, aiding in the diagnosis of conditions such as cancer. Variants include fine-needle aspiration, core needle, and vacuum-assisted biopsies. This effective diagnostic tool ensures quicker recovery and reduced complications compared to traditional surgical biopsies.
Global Needle Biopsy Market Dynamics
Drivers
- Rising Cancer Screening and Early Detection
Needle biopsies play a crucial role in cancer screening and early detection by identifying genetic mutations through a blood test. This non-invasive approach allows for the detection of cancer in its early stages, enhancing the chances of successful treatment and improving patient outcomes.
- Expanding Applications in Various Medical Specialties
Needle biopsy procedures, once primarily associated with oncology, are diversifying into broader medical applications. Their utility extends to infectious diseases and inflammatory conditions, marking a paradigm shift in diagnostic versatility. This expansion into various medical specialties propels the growth of the needle biopsy market, addressing a broader spectrum of diagnostic needs beyond traditional oncological applications.
Opportunities
- Rising Geriatric Population Escalating Demand for Diagnostic Tools
The growing geriatric population, with an increased susceptibility to various cancers, is a pivotal opportunity for the needle biopsy market. This demographic shift highlights a substantial opportunity in oncological diagnostics. Needle biopsies, vital for precise and minimally invasive cancer diagnosis, cater to the escalating demand for effective diagnostic tools, particularly in addressing the healthcare needs of the elderly.
- Minimally Invasive Procedures Enhancing Accessibility
The surge in minimally invasive procedures fuels the adoption of needle biopsies, driven by their advantages of minimizing patient discomfort, shortening recovery periods, and enhancing accessibility across diverse clinical applications. This trend aligns with the evolving healthcare landscape, emphasizing patient-centric approaches and contributing to the widespread acceptance of needle biopsy techniques.
Restraints/Challenges
- Regulatory Compliance for Healthcare Providers
Navigating stringent regulatory requirements and staying updated on evolving standards pose significant challenges for manufacturers and healthcare providers in the needle biopsy market. Ensuring compliance demands continuous efforts and resources, impacting market dynamics and the development of needle biopsy technologies. The market faces a substantial challenge in meeting and adapting to these regulatory complexities.
- High Equipment Costs Limits Accessibility
High equipment costs in needle biopsy procedures present financial hindrance for healthcare facilities, limiting accessibility and hindering widespread adoption. The financial burden associated with acquiring and maintaining necessary equipment impedes market growth, impacting both the market's expansion and overall healthcare accessibility for patients in need of these crucial diagnostic procedures.
This global needle biopsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2022, Limaca Medical secured FDA breakthrough device status for its Precision-GI endoscopic ultrasound biopsy needle. This innovative, automated rotational cutting needle is designed to minimize issues such as tissue fragmentation, insufficient sample quantity, and blood contamination during biopsies
- In January 2021, Hologic, Inc. acquired SOMATEX Medical Technologies GmbH for $64 million, increasing its breast cancer treatment offerings. The acquisition enhances Hologic's capability to offer diverse solutions for breast cancer, particularly through expanding its portfolio of biopsy site biomarkers
- In August 2020, Hologic Inc innovated the Brevera Breast Needle Biopsy System with CorLumina Imaging Technology. The CorLumina Imaging Technology, incorporates vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one integrated system
- In February 2020, Moller Möller Medical GmbH launched the diagnostic product application of full-sCore technology for biopsies. The sCore Technology in needle biopsies consists of the well-adjusted crown cut core, which ensures less traumatic puncture and accurate diagnosis and collection of tissue. An echogenic distal tip ensures superb visibility under ultrasound-guided biopsy
Global Needle Biopsy Market Scope
The global needle biopsy market is segmented on the basis of the needle type, ergonomics, product, procedure, sample site, utility, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Needle Type
- Trephine Biopsy Needles
- Klima Sternal Needle
- Salah Needle Aspiration Needle
- Jamshidi Needle
- Others
Ergonomics
- Sharp
- Blunt
- Quincke
- Chiba
- Franseen
- Others
Product
- Fine-Needle Aspiration Biopsy
- Core Needle Biopsy
- Vacuum-Assisted Biopsy
- Image-Guided Biopsy
- Needle Based Biopsy Guns
- Biopsy Needles
Procedure
- Image-Guided Procedures
- Ultrasound-Guided Procedures
- Stereotactic Procedures
- CT-Guided Procedures
- MRI-Guided Procedures
- Other Procedures
Sample Site
- Muscles
- Bones
- Other Organs
Utility
- Disposable
- Reusable
Application
- Tumour/Cancer
- Breast
- Lung
- Prostate
- Colon
- Stomach
- Liver
- Cervix Uteri
- Thyroid
- Infection
- Inflammation
- Others
End User
- Hospitals
- Diagnostic Centres
- Biopsy Labs
- Ambulatory Surgical Centres
- Academic and Research Organizations
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Global Needle Biopsy Market Regional Analysis/Insights
The global needle biopsy market is analysed and market size insights and trends are provided by country, needle type, ergonomics, product, procedure, sample site, utility, application, end user and distribution channel as referenced above.
The countries covered in the global needle biopsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the global needle biopsy market, driven by its extensive consumer base and a high GDP. The U.S. takes the forefront, benefitting from FDA approvals, technological advancements, and a surge in clinical trials. The fine-needle aspiration biopsy segment dominates, offering cost-effective and accurate treatment, particularly in addressing rising breast cancer cases and an aging population.
Europe is expected to dominate the needle biopsy market, driven by untapped opportunities in Germany and the presence of leading cancer research institutes. Within this landscape, the fine-needle aspiration biopsy segment is poised for dominance, fueled by growing preference for minimally invasive procedures.
Asia-Pacific is expected to grow with the highest CAGR in the global needle biopsy market from 2024 to 2031. China is anticipated to dominate, driven by heightened cancer awareness, favorable reimbursement, and improved healthcare infrastructure. The fine-needle aspiration biopsy segment is expected to lead, supported by collaborations between healthcare entities and market players in China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global needle biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global needle biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global needle biopsy market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Needle Biopsy Market Share Analysis
The global needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global needle biopsy market.
Some of the major players operating in the global needle biopsy market are:
- Medax (Italy)
- Boston Scientific Corporation (U.S.)
- Cook Group (U.S.)
- Hologic, Inc. (U.S.)
- ST. STONE MEDICAL DEVICES PVT. LTD. (India)
- AprioMed AB (Sweden)
- AMECATH (Egypt)
- ZAMAR CARE. (Croatia)
- Cardinal Health (U.S.)
- INRAD, Inc. (U.S.)
- BD (U.S.)
- MÖLLER Medical GmbH (Germany)
- HAKKO CO.,LTD. (Japan)
- Argon Medical Devices (U.S.)
- Merit Medical Systems. (U.S.)
- weLLgo Medical Products GmbH (Germany)
- Swastik Enterprise (India)
- Tsunami Medical (Italy)
- PAJUNK (Germany)
- B. Braun SE (Germany)
SKU-